ConductScience.org, home

Paper41007669

Nanoparticle-Delivered Rutin Prevents Metabolic and Oxidative Imbalance in Obesity Triggered by a High-Fat Diet: In Vivo and In Silico Studies.

Zahran NH and 3 others. Biomedicines, 2025. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Nanoparticle-Delivered Rutin Prevents Metabolic and Oxidative Imbalance in Obesity Triggered by a High-Fat Diet: In Vivo and In Silico Studies. Papers, record 41007669. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41007669

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Nanoparticle-Delivered Rutin Prevents Metabolic and Oxidative Imbalance in Obesity Triggered by a High-Fat Diet: In Vivo and In Silico Studies.
PubMed
Journal
Biomedicines
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Revised in PubMed
2025-09-30
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zahran NHNourhan Hhttps://orcid.org/0009-0004-8984-0950
2Abu-Elsaoud AMAbdelghafar Mhttps://orcid.org/0000-0002-6269-3418
3Mohamed ASAyman Saber
4Marie OMOhoud Mhttps://orcid.org/0000-0003-2846-8476

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
IMSIU-DDRSP2501Deanship of Scientific Research at Imam Mohammad Ibn Saud Islamic University (IMSIU)PubMed

Source PubMed

Download CSV of grants

References69

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118081207Phenolic compounds: evidence for inhibitory effects against obesity and their underlying molecular signaling mechanisms.Mol Nutr Food Res2008https://conductscience.org/library/papers/18081207PubMed
226740599PPARγ Antagonist Gleevec Improves Insulin Sensitivity and Promotes the Browning of White Adipose Tissue.Diabetes2016https://conductscience.org/library/papers/26740599PubMed
339858438The Metabolism of Creatinine and Its Usefulness to Evaluate Kidney Function and Body Composition in Clinical Practice.Biomolecules2025https://conductscience.org/library/papers/39858438PubMed
437296533Obesity, Hyperfiltration, and Early Kidney Damage: A New Formula for the Estimation of Creatinine Clearance.J Clin Endocrinol Metab2023https://conductscience.org/library/papers/37296533PubMed
534552557Obesity: Epidemiology, Pathophysiology, and Therapeutics.Front Endocrinol (Lausanne)2021https://conductscience.org/library/papers/34552557PubMed
621498783Altered skeletal muscle lipase expression and activity contribute to insulin resistance in humans.Diabetes2011https://conductscience.org/library/papers/21498783PubMed
732466230Effect of Deglycosylated Rutin by Acid Hydrolysis on Obesity and Hyperlipidemia in High-Fat Diet-Induced Obese Mice.Nutrients2020https://conductscience.org/library/papers/32466230PubMed
818458706The clinical biochemistry of obesity.Clin Biochem Rev2004https://conductscience.org/library/papers/18458706PubMed
931982449Anti-obesity effect of trans-cinnamic acid on HepG2 cells and HFD-fed mice.Food Chem Toxicol2020https://conductscience.org/library/papers/31982449PubMed
1039961502The impact of oxidative stress on abnormal lipid metabolism-mediated disease development.Arch Biochem Biophys2025https://conductscience.org/library/papers/39961502PubMed
1121855698Obesity and dyslipidemia.Med Clin North Am2011https://conductscience.org/library/papers/21855698PubMed
1235205027Obesity: Treatments, Conceptualizations, and Future Directions for a Growing Problem.Biology (Basel)2022https://conductscience.org/library/papers/35205027PubMed
1326425466Profile of liver enzymes in non-alcoholic fatty liver disease in patients with impaired glucose tolerance and newly detected untreated type 2 diabetes.Indian J Endocrinol Metab2015https://conductscience.org/library/papers/26425466PubMed
1433364879The Relationship between Insulin Resistance and Liver Damage in non-alcoholic Fatty Liver Patients.Sisli Etfal Hastan Tip Bul2020https://conductscience.org/library/papers/33364879PubMed
1537512578
Anti-Obesity Effect of a Tea Mixture Nano-Formulation on Rats Occurs via the Upregulation of AMP-Activated Protein Kinase/Sirtuin-1/Glucose Transporter Type 4 and Peroxisome Proliferator-Activated Receptor Gamma Pathways.
Metabolites2023https://conductscience.org/library/papers/37512578PubMed
1637886008Rutin mitigates perfluorooctanoic acid-induced liver injury via modulation of oxidative stress, apoptosis, and inflammation.Iran J Basic Med Sci2023https://conductscience.org/library/papers/37886008PubMed
1730701776Intrahepatic cholestasis in nonalcoholic fatty liver disease.Ter Arkh2018https://conductscience.org/library/papers/30701776PubMed
1833116712Obesity, Insulin Resistance, and Type 2 Diabetes: Associations and Therapeutic Implications.Diabetes Metab Syndr Obes2020https://conductscience.org/library/papers/33116712PubMed
1923584084Dyslipidemia in obesity: mechanisms and potential targets.Nutrients2013https://conductscience.org/library/papers/23584084PubMed
2011037963Leptin in the regulation of immunity, inflammation, and hematopoiesis.J Leukoc Biol2000https://conductscience.org/library/papers/11037963PubMed

See all 69 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42941771Metabolic Milieu and Susceptibility: The Combined Benefits of Targeting AMPK and ACE2 for Metabolic Disorders and COVID-19.Int J Mol Sci2026https://conductscience.org/library/papers/42941771PubMed
42159845Niosomal Gallic Acid Attenuates Obesity-related Hepatic Steatosis Through Oxidative and Inflammatory Regulation With Associated Autophagy and Hedgehog Pathway Modulation.Appl Biochem Biotechnol2026https://conductscience.org/library/papers/42159845PubMed
42016235Obesity and Natural Products: Mechanisms, Therapeutic Potential, and Future Directions.Food Sci Nutr2026https://conductscience.org/library/papers/42016235PubMed
41893254Green-Synthesized Rutin-Capped Gold Nanoparticles Attenuate Experimental Liver Fibrosis by Targeting Oxidative Stress and TGF-β Signaling.Nanomaterials (Basel)2026https://conductscience.org/library/papers/41893254PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41007669

GET https://conductscience.org/api/papers/v1/41007669/references?page=2